| Trial ID: | L2380 |
| Source ID: | NCT00371982
|
| Associated Drug: |
Fish Oil (Maxepa)
|
| Title: |
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Fish oil (Maxepa)
|
| Outcome Measures: |
Primary: The effect of 2 month treatment on:|adiposity (total fat mass, adipocyte morphology), atherogenic markers and insulin sensitivity | Secondary: the underlying mechanisms of the observed results and tried to define new targets of fish oil metabolic effects|and the impact of fish oil on systemic inflammatory markers and adipose tissue inflammatory genes.
|
| Sponsor/Collaborators: |
Sponsor: Assistance Publique - Hôpitaux de Paris | Collaborators: Institut National de la Santé Et de la Recherche Médicale, France
|
| Gender: |
FEMALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-12
|
| Completion Date: |
2005-04
|
| Results First Posted: |
|
| Last Update Posted: |
2006-09-04
|
| Locations: |
Department of Diabetes-Hotel Dieu Hospital, Paris, 75004, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00371982
|
